Evaluation of Fracture Risk Among Patients With Type 2 Diabetes and Nonvalvular Atrial Fibrillation Receiving Different Oral Anticoagulants.
David Tak Wai LuiEric Ho Man TangIvan Chi Ho AuTingting WuChi Ho LeeChun Ka WongChloe Yu Yan CheungCarol Ho Yi FongWing Sun ChowYu Cho WooKathryn Choon Beng TanKaren Siu-Ling LamCarlos King-Ho WongPublished in: Diabetes care (2022)
NOAC use was associated with a lower risk of major osteoporotic fractures than warfarin use among patients with type 2 diabetes comorbid with AF. NOAC may be the preferred anticoagulant from the perspective of bone health.
Keyphrases
- oral anticoagulants
- atrial fibrillation
- bone mineral density
- left atrial
- catheter ablation
- direct oral anticoagulants
- left atrial appendage
- healthcare
- public health
- heart failure
- postmenopausal women
- percutaneous coronary intervention
- mental health
- health information
- body composition
- health promotion
- hip fracture
- venous thromboembolism
- risk assessment
- mitral valve